LU88317I2 - Chlorhydrate d'esmolol (Brevibloc) - Google Patents

Chlorhydrate d'esmolol (Brevibloc)

Info

Publication number
LU88317I2
LU88317I2 LU88317C LU88317C LU88317I2 LU 88317 I2 LU88317 I2 LU 88317I2 LU 88317 C LU88317 C LU 88317C LU 88317 C LU88317 C LU 88317C LU 88317 I2 LU88317 I2 LU 88317I2
Authority
LU
Luxembourg
Prior art keywords
brevibloc
myocardial infarction
esmolol hydrochloride
acute myocardial
compounds
Prior art date
Application number
LU88317C
Other languages
English (en)
Original Assignee
Du Pont Merck Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont Merck Pharma filed Critical Du Pont Merck Pharma
Publication of LU88317I2 publication Critical patent/LU88317I2/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Steroid Compounds (AREA)
LU88317C 1980-06-02 1993-06-16 Chlorhydrate d'esmolol (Brevibloc) LU88317I2 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8004087A SE8004087L (sv) 1980-06-02 1980-06-02 Nya parasubstituerade 3-fenoxi-1-alkylaminopropanol-2-er med betareceptorblockerande egenskaper, samt forfarande for deras framstellning, farmaceutiska beredningar innehallande desamma, och metod att behandla akut ...

Publications (1)

Publication Number Publication Date
LU88317I2 true LU88317I2 (fr) 1994-05-04

Family

ID=20341101

Family Applications (2)

Application Number Title Priority Date Filing Date
LU88317C LU88317I2 (fr) 1980-06-02 1993-06-16 Chlorhydrate d'esmolol (Brevibloc)
LU88348C LU88348I2 (fr) 1980-06-02 1993-06-30 Chlorhydrate d'esmolol (Brevibloc)

Family Applications After (1)

Application Number Title Priority Date Filing Date
LU88348C LU88348I2 (fr) 1980-06-02 1993-06-30 Chlorhydrate d'esmolol (Brevibloc)

Country Status (25)

Country Link
EP (1) EP0041491B1 (fr)
JP (1) JPS5724335A (fr)
KR (1) KR850000869B1 (fr)
AT (1) ATE11529T1 (fr)
AU (1) AU548290B2 (fr)
CS (1) CS241484B2 (fr)
DD (1) DD159328A5 (fr)
DE (1) DE3168595D1 (fr)
DK (1) DK154208C (fr)
ES (1) ES8300679A1 (fr)
FI (1) FI71725C (fr)
GR (1) GR74571B (fr)
HU (1) HU184860B (fr)
IE (1) IE53801B1 (fr)
LU (2) LU88317I2 (fr)
MY (1) MY8600219A (fr)
NL (1) NL930102I2 (fr)
NO (1) NO151282C (fr)
NZ (1) NZ197237A (fr)
PH (1) PH16135A (fr)
PL (1) PL135823B1 (fr)
PT (1) PT73111B (fr)
SE (1) SE8004087L (fr)
SU (1) SU1156592A3 (fr)
ZA (1) ZA812981B (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4593119A (en) * 1980-11-28 1986-06-03 American Hospital Supply Corporation Method for treatment or prophylaxis of cardiac disorders
US4387103A (en) * 1980-11-28 1983-06-07 American Hospital Supply Corporation Method for treatment or prophylaxis of cardiac disorders
US4454154A (en) * 1981-06-23 1984-06-12 American Hospital Supply Corporation Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents
US4578403A (en) * 1981-06-23 1986-03-25 American Hospital Supply Corporation Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents
US4559359A (en) * 1981-06-23 1985-12-17 American Hospital Supply Corporation Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents
US4455317A (en) * 1981-06-23 1984-06-19 American Hospital Supply Corporation Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents
US5135926A (en) * 1984-03-14 1992-08-04 Bodor Nicholas S Soft β-adrenergic blocking agents
US5202347A (en) * 1984-03-14 1993-04-13 Bodor Nicholas S Soft β-adrenergic blocking agents
US5334601A (en) * 1984-03-14 1994-08-02 Bodor Nicholas S Soft β-adrenergic blocking agents
US4829086A (en) * 1984-03-14 1989-05-09 Bodor Nicholas S Soft β-adrenergic blocking agents
EP0174956B1 (fr) * 1984-03-14 1990-08-16 BODOR, Nicholas S. AGENTS DE BLOCAGE $g(b)-ADRENERGIQUES DOUX
WO1985004580A1 (fr) * 1984-04-09 1985-10-24 American Hospital Supply Corporation Composition pharmaceutique et procede de traitement ou de prophylaxie d'affections cardiaques
EP0279844A4 (fr) * 1986-09-02 1990-06-05 Du Pont AFLÖSUNG VON DE dl-METHYL-3-4-(2-HYDROXY-3-ISOPROPYLAMINO)PROPOXY]PHENYLPROPIONAT (DL-ESMOLOL)].
US5274002A (en) * 1987-04-14 1993-12-28 Warner-Lambert Company Trisubstituted phenyl analogs having activity for congestive heart failure
CA2015730C (fr) * 1989-05-12 1997-10-07 Sadahiko Iguchi Esters de l'acide phenylalcanoique
US5232948A (en) * 1990-09-10 1993-08-03 Rhone-Poulenc Rorer Pharmaceuticals Inc. Substituted monocyclic aryl compounds exhibiting selective leukotriene b4 antagonist activity
GT200600381A (es) 2005-08-25 2007-03-28 Compuestos organicos
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
ES2382009T3 (es) 2006-12-01 2012-06-04 Bristol-Myers Squibb Company Derivados de N-((3-bencil)-2,2-(bis-fenil-)-propan-1-amina como inhibidores de CETP para el tratamiento de aterosclerosis y enfermedades cardiovasculares
CN105143203A (zh) 2013-04-17 2015-12-09 辉瑞大药厂 用于治疗心血管疾病的n-哌啶-3-基苯甲酰胺衍生物
US20160333948A1 (en) * 2014-01-29 2016-11-17 Sumitomo Bakelite Co., Ltd. Brake pad and caliper device
WO2016055901A1 (fr) 2014-10-08 2016-04-14 Pfizer Inc. Composés d'amide substitué
WO2020150473A2 (fr) 2019-01-18 2020-07-23 Dogma Therapeutics, Inc. Inhibiteurs de pcsk9 et leurs procédés d'utilisation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB673413A (en) * 1950-03-22 1952-06-04 Rhone Poulenc Sa New local anaesthetics which are substituted benzoic esters and processes for making the same
NL163775C (nl) * 1967-12-18 1980-10-15 Boehringer Sohn Ingelheim Werkwijze ter bereiding van farmaceutische preparaten met beta-receptoren blokkerende werking, alsmede werkwijze ter bereiding van 1-(cyaanfenoxy)-2-hydroxy-3-(sec.alkylamino) propaanderivaten.
GB1285038A (en) 1969-02-21 1972-08-09 Ici Ltd Alkanolamine derivatives
SE354851B (fr) * 1970-02-18 1973-03-26 Haessle Ab
FR2132570B1 (fr) 1971-04-09 1974-08-02 Lipha
PT66890B (fr) * 1976-08-21 1979-01-25 Hexachimie Procede pour la preparation des aryloxy-1 amino-3 propanol-2

Also Published As

Publication number Publication date
NO811799L (no) 1981-12-03
ATE11529T1 (de) 1985-02-15
HU184860B (en) 1984-10-29
NL930102I2 (nl) 1994-12-01
FI71725C (fi) 1987-02-09
NL930102I1 (nl) 1993-10-01
KR850000869B1 (ko) 1985-06-22
IE53801B1 (en) 1989-03-01
DK154208C (da) 1989-03-20
ZA812981B (en) 1982-05-26
PL231450A1 (en) 1983-03-28
KR830006177A (ko) 1983-09-20
DE3168595D1 (en) 1985-03-14
DK239581A (da) 1981-12-03
AU7116681A (en) 1982-12-02
ES502656A0 (es) 1982-11-01
CS241484B2 (en) 1986-03-13
DD159328A5 (de) 1983-03-02
SE8004087L (sv) 1981-12-03
NZ197237A (en) 1985-01-31
PL135823B1 (en) 1985-12-31
EP0041491A1 (fr) 1981-12-09
DK154208B (da) 1988-10-24
ES8300679A1 (es) 1982-11-01
JPS639501B2 (fr) 1988-02-29
PT73111B (en) 1983-05-11
FI71725B (fi) 1986-10-31
AU548290B2 (en) 1985-12-05
GR74571B (fr) 1984-06-29
IE811217L (en) 1981-12-02
NO151282C (no) 1985-03-13
EP0041491B1 (fr) 1985-01-30
JPS5724335A (en) 1982-02-08
FI811671L (fi) 1981-12-03
CS404781A2 (en) 1985-06-13
PT73111A (en) 1981-07-01
LU88348I2 (fr) 1994-09-09
MY8600219A (en) 1986-12-31
NO151282B (no) 1984-12-03
SU1156592A3 (ru) 1985-05-15
PH16135A (en) 1983-07-08

Similar Documents

Publication Publication Date Title
LU88348I2 (fr) Chlorhydrate d'esmolol (Brevibloc)
JPS5724334A (en) Novel substituted 3-phenoxy-1-alkoxycarbonyl alkylamino-propanol-2 compound
DE3362260D1 (en) (-)-15-deoxyspergualin, a process for the preparation of the same, and a pharmaceutical composition containing the same
DE3576687D1 (de) Chinatsalze der antimalarischen verbindung mefloquin.
ATE71091T1 (de) Tetrahydro-1,2,4-oxadiazin-5-thion-derivate.